CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 8-K Event Results of operations
- 10-Q/A Report 10-Q/A
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 8-K Event Other events
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- SC 13G Stake Amended Statement of Ownership
- 4 Grant or award President and Chief Executive acquired 7,500 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 7,500 shares (grant or award)
- 4 Grant or award CFO and CBO acquired 7,500 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 25 · 496 filings